State Street SPDR S&P Pha... (XPH)
NYSEArca: XPH
· 실시간 가격 · USD
72.45
+2.03 (2.88%)
종가 기준: Aug 18, 2026, 3:59 PM
State Street SPDR S&P Pharmaceuticals ETF (XPH) ETF Price, Holdings & Analysis
2.88% (1D)
| 매수호가 | 0 |
| 시가총액 | n/a |
| 운용자산 | 489.39M |
| 순자산가치 | 70.50 |
| 베타 | 0.7 |
| EPS (최근 12개월) | n/a |
| P/E (최근 12개월) | 19.15 |
| 발행 주식수 | 5.5M |
| 설정일 | Jun 19, 2006 |
| 매도호가 | 0 |
| 거래량 | 121,770 |
| 평균 거래량 (20일) | 95,196 |
| 시가 | 71.10 |
| 전일 종가 | 70.42 |
| 당일 변동폭 | 71.06 - 72.48 |
| 52주 변동폭 | 45.80 - 72.49 |
| 편입 종목 | n/a |
| 총보수 | 0.35% |
XPH 정보
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
상위 10종목 자산의 25.66%
| 이름 | 종목코드 | 비중 |
|---|---|---|
| Crinetics Pharmaceut... | CRNX | 3.69% |
| Mbx Biosciences Inc | MBX | 3.22% |
| Ataibeckley Inc | ATAI | 2.88% |
| Definium Therapeutic... | DFTX | 2.84% |
| Amylyx Pharmaceutica... | AMLX | 2.29% |
| Enliven Therapeutics... | ELVN | 2.24% |
| Corcept Therapeutics... | CORT | 2.22% |
| Alumis Inc | ALMS | 2.13% |
| Nuvation Bio Inc Ord... | NUVB | 2.09% |
| Trevi Therapeutics I... | TRVI | 2.06% |
배당 배당수익률 0.46%
| 배당락일 | 금액 | 지급일 |
|---|---|---|
| Jun 22, 2026 | $0.0590 | n/a |
| Mar 23, 2026 | $0.0610 | n/a |
| Dec 22, 2025 | $0.1130 | n/a |
| Sep 22, 2025 | $0.1030 | n/a |
| Jun 23, 2025 | $0.0960 | n/a |
2 페이지 중 1